Flaharty Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $560K | Sell |
|
|||||
|
2021
Q1 | $477K | Sell |
|
|||||
|
2020
Q4 | $3.83M | Sell |
|
|||||
|
2020
Q3 | $3.13M | Hold |
|
|||||
|
2020
Q2 | $3.06M | Hold |
|
|||||
|
2020
Q1 | $2.45M | Buy |
|
|||||
|
2019
Q4 | $2.72M | Sell |
|
|||||
|
2019
Q3 | $2.65M | Hold |
|
|||||
|
2019
Q2 | $3.55M | Sell |
|
|||||
|
2019
Q1 | $3.67M | Sell |
|
|||||
|
2018
Q4 | $2.74M | Hold |
|
|||||
|
2018
Q3 | $3.85M | Sell |
|
|||||
|
2018
Q2 | $3.5M | Sell |
|
|||||
|
2018
Q1 | $3.22M | Sell |
|
|||||
|
2017
Q4 | $3.73M | Sell |
|
|||||
|
2017
Q3 | $4.43M | Buy |
|
|||||
|
2017
Q2 | $3.89K | Sell |
|
|||||
|
2017
Q1 | $3.65M | Buy |
|